373 related articles for article (PubMed ID: 28910921)
1. [Effectiveness of rapid hepatitis B vaccination with different vaccine dosages and types in adults].
Nie L; Pang XH; Zhang Z; Ma JX; Liu XY; Qiu Q; Liang Y; Li Q; Zhang W
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1151-1155. PubMed ID: 28910921
[No Abstract] [Full Text] [Related]
2. [Anti-HBs persistence following revaccination with three doses of hepatitis B vaccine among low-responsive adults after primary vaccination: a 4-year follow-up study].
Lyu JJ; Yin XW; Yan BY; Liu JY; Feng Y; Wu WL; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang L; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):491-6. PubMed ID: 27256727
[TBL] [Abstract][Full Text] [Related]
3. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
[TBL] [Abstract][Full Text] [Related]
4. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among non-responsive adults: a 4-year of follow-up study].
Zhang L; Yan BY; Lyu JJ; Liu JY; Feng Y; Wu WL; Cao CZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):497-502. PubMed ID: 27256728
[TBL] [Abstract][Full Text] [Related]
5. [Antibody persistence following booster vaccination with three doses of hepatitis B vaccines among low-response adults in Zhangqiu county of Shandong province: 24-month of follow-up from 2009].
Yan B; Lyu J; Liu J; Feng Y; Xu A; Chen S; Zhou L; Liang X; Cui F; Wang F; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2014 Dec; 48(12):1043-7. PubMed ID: 25619213
[TBL] [Abstract][Full Text] [Related]
6. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccines among non-responsive adults: 24-month of follow-up].
Zhang L; Lyu J; Yan B; Liu J; Feng Y; Chen S; Zhou L; Liang X; Cui F; Wang F; Xu A
Zhonghua Yu Fang Yi Xue Za Zhi; 2015 Sep; 49(9):782-7. PubMed ID: 26733135
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of antibody persistence after primary immunization with 5 μg and 10 μg recombinant hepatitis B vaccine among newborns with normal and high response: a five-year following-up].
Zhang L; Zhang W; Lyu JJ; Zhang JJ; Liu JY; Yan BY; Feng Y; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Sep; 38(9):1156-1160. PubMed ID: 28910922
[No Abstract] [Full Text] [Related]
8. [Antibody persistence following primary vaccination with hepatitis B vaccine among normal and high-responder adults: a 5-year follow-up study].
Wu WL; Yan BY; Lyu JJ; Liu JY; Feng Y; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Zhang GM; Zhang L; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):484-90. PubMed ID: 27256726
[TBL] [Abstract][Full Text] [Related]
9. [Matching study on immune response between single anti-HBc positivity and healthy adults after primary immunization and revaccination of hepatitis B vaccine].
Liu J; Lyu J; Yan B; Feng Y; Zhang L; Xu A
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 Oct; 35(10):1091-4. PubMed ID: 25567010
[TBL] [Abstract][Full Text] [Related]
10. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
[TBL] [Abstract][Full Text] [Related]
11. [The effect of booster dose vaccination 21- to 32-years after primary vaccination with hepatitis B vaccine in the population born from 1986 to 1996 in Zhengding County of Hebei Province].
Zhang XJ; Wu ZW; Zhang YH; Li MJ; Zhou HS; Han BH; Hao ZY; Chu J; Gao Z; Ma JC; Zhao YL
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):942-946. PubMed ID: 32907282
[No Abstract] [Full Text] [Related]
12. [Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults].
Feng Y; Yan BY; Zhang L; Lü JJ; Liu JY; Gong XH; Cui FQ; Liang XF; Chen SY; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):813-7. PubMed ID: 23157885
[TBL] [Abstract][Full Text] [Related]
13. [Anti-HBs persistence after revaccination with three doses of hepatitis B vaccine among low-responder infants following primary vaccination: 4-year of follow-up].
Lyu JJ; Yan BY; Liu JY; Feng Y; Wu WL; Liang XF; Cui FQ; Wang FZ; Zhang GM; Xu AQ; Zhang L
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):490-495. PubMed ID: 28592091
[No Abstract] [Full Text] [Related]
14. Antibody response to revaccination among adult non-responders to primary Hepatitis B vaccination in China.
Zhang L; Liu J; Lu J; Yan B; Song L; Li L; Cui F; Zhang G; Wang F; Liang X; Xu A
Hum Vaccin Immunother; 2015; 11(11):2716-22. PubMed ID: 26252481
[TBL] [Abstract][Full Text] [Related]
15. [Study on the immuno-effects and influencing factors of Chinese hamster ovary (CHO) cell hepatitis B vaccine among adults, under different dosages].
Zhang W; Lin CY; Han LL; Li LQ; Gao P; Lin H; Gong XH; Huang F; Tang YQ; Ma JX; Zhang HY; Wang C; Yang P; Li H; Sun MP; He X; Pang XH
Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Jul; 31(7):767-70. PubMed ID: 21162840
[TBL] [Abstract][Full Text] [Related]
16. Immune response to different types of hepatitis B vaccine booster doses 2-32 years after the primary immunization schedule and its influencing factors.
Zhao YL; Pan LL; Hao ZY; Jin F; Zhang YH; Li MJ; Zhang XJ; Han BH; Zhou HS; Ma TL; Wang F; Ma JC; Shen LP; Li Q
Int J Infect Dis; 2020 Apr; 93():62-67. PubMed ID: 32004687
[TBL] [Abstract][Full Text] [Related]
17. [Persistence of immune memory and its related factors at 12 years after hepatitis B vaccination among adults].
Zhang L; Yan BY; Lyu JJ; Liu JY; Kong Q; Wu WL; Feng Y; Xu AQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 May; 53(5):497-502. PubMed ID: 31091608
[No Abstract] [Full Text] [Related]
18. Comparison of the effectiveness four years after Homo/Hetero prime-boost with 10 μg HP and 20 μg CHO recombinant hepatitis B vaccine at 1 and 6 months in maternal HBsAg-negative children.
Yin Z; Wen T; Fu C; Li J; Fang Q; Gong X; You J; Wang S; Zheng C
Front Immunol; 2024; 15():1308238. PubMed ID: 38660313
[TBL] [Abstract][Full Text] [Related]
19. [Combined immunoprophylaxis induces changes in anti-hepatitis B surface protein titer in infants born to mothers with positivity for hepatitis B surface antigen].
Wang J; Feng YL; Liu MH; Bai Y; Feng DH; Yuan NX; Du DQ; Feng WH; Liu HL; Yang Y; Liu JF; He YL; Song HX; Liu Y; Zhao YR; Chen TY
Zhonghua Gan Zang Bing Za Zhi; 2013 Aug; 21(8):580-3. PubMed ID: 24119736
[TBL] [Abstract][Full Text] [Related]
20. [The epidemiological characteristics of HBV susceptibility in 1-29 years old young people in China in 2006 and 2014: based on the national sero-survey data analysis].
Zheng H; Wang FZ; Zhang GM; Miao N; Sun XJ; Cui FQ
Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jul; 51(7):581-586. PubMed ID: 28693080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
